Evidence map›Paper›PMID 30796071›Full record

ArticleBMJ case reports2019

Retinal and choroidal circulation determined by optical coherence tomography angiography in patient with amyloidosis.

Masami Tei, Ichiro Maruko, Eiko Uchimura, Tomohiro Iida

Open access · hybridAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Angiographic dark choroid in systemic non-hereditary amyloidosis.American journal of ophthalmology case reports · 2022
    Article
  2. Long-term follow-up of a case of amyloidosis-associated chorioretinopathy.American journal of ophthalmology case reports · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Masami TeiOphthalmology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Ichiro MarukoOphthalmology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Eiko UchimuraOphthalmology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Tomohiro IidaOphthalmology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Tokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 43-year-old woman who was diagnosed with the cryopyrine-associated periodic syndrome (CAPS) with severe renal failure and heart failure due to amyloid accumulation was examined by swept source optical cohernce tomography (OCT) (SS-OCT; DRI-OCT, Topcon, Tokyo, Japan) and optical coherence tomography angiography (OCTA) (RTVue XR Avanti, Optovue, Fremont, CA). Her best-corrected visual acuity was 20/40 OD and 20/25 OS. A hyporeflective band of about 100 µm thickness was seen just inferior to the retinal pigment epithelium in the cross-sectional SS-OCT images, but the deeper choroidal structures were clearly visible. In the OCTA images, the density of the retinal capillaries in the superficial and deep capillary plexus slabs were reduced, and no signals of the choroidal capillary slab was detected after removing the projection artefacts. The accumulation of amyloid can cause a reduction of both the retinal and choroidal capillary circulations although the circulation in the larger vessels are preserved.

Indexed as

Tomography, Optical CoherenceAdultAmyloidosisChoroidCryopyrin-Associated Periodic SyndromesFemaleFluorescein AngiographyHeart FailureHumansRenal InsufficiencyRetinal VesselsTreatment Outcomemacularetina

Identifiers

PMID30796071
PMCPMC6388794
OpenAlexW2916302722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.